Gastroenterology & Hepatology

Samer Gawrieh, MD Publications

MANUSCRIPTS

1.        Charlton M, Angulo P, Chalasani N, Merriman R, Viker K, Charatcharoenwitthaya P, Sanderson S, Gawrieh S, Krishnan A, Lindor K. Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology. 2007 Dec 27;47(2):484-492.

2.        Gawrieh S, Shaker R. A. Pilotto, P. Malfertheiner and Peter R. Holt. Aging and the Gastrointestinal Tract, Book Review. Gastroenterology. 2007 Mar; 132(3):1196.

3.        Gawrieh S, Carroll T, Hogan WJ, Soergel KH, Shaker R. Swallow syncope in association with schatzki ring and hypertensive esophageal peristalsis: report of three cases and review of the literature. Dysphagia. 2005 Fall;20(4):273-7

4.        Gawrieh S, Papouchado BG, Burgart  LJ, Kobayashi S, Charlton MR, Gores GJ.  Early Hepatic Stellate Cell Activation Predicts Severe Hepatitis C Recurrence after Liver Transplantation. Liver Transpl. 2005 Oct;11(10):1207-13.

5.        Gawrieh S, Shaker R. Treatment of actively bleeding Mallory-Weiss syndrome: epinephrine injection or band ligation? Curr Gastroenterol Rep. 2005 Jun;7(3):175.

6.         Gawrieh S, Shaker R. Variceal band ligation versus propranolol for primary prophylaxis of variceal bleeding in cirrhosis. Curr Gastroenterol Rep. 2005 Jun;7(3):175-6.

7.        Gawrieh S, Opara EC, Koch TR. Oxidative stress in nonalcoholic fatty liver disease: pathogenesis and antioxidant therapies. J Investig Med. 2004 Dec;52(8):506-14.

8.        Gawrieh S, Saeian K. Management of esophageal varices: an update from Digestive Disease Week and American Association for the Study of Liver Diseases 2003. Curr Gastroenterol Rep. 2004 Jun;6(3):206-9.

9.        Gawrieh S, Shaker R. Treatment options for eosinophilic esophagitis: montelukast. Curr Gastroenterol Rep. 2004 Jun;6(3):190.

10.       Gawrieh S, Shaker R. Treatment options for eosinophilic esophagitis: elemental diet.Curr Gastroenterol Rep. 2004 Jun;6(3):189.

11.      Kaplan MS, Gawrieh S, Cotler SJ, Jensen DM. Neutralizing antibodies in hepatitis c virus infection: a review of immunological and clinical characteristics. Gastroenterology 2003 Aug;125(2):597-604.

12.      Gawrieh S, Shaker, R. Medical management of nocturnal symptoms of gastroesophageal reflux disease in the elderly. Drugs Aging 2003:20(7)509-16.

13.       Gawrieh S, Koch TR. Effect of ursodeoxycholic acid on methionine adenosyltransferase activity and hepatic glutathione metabolism in rats. Rodriguez-Ortigosa CM, Cincu RN, Sanz S, et al.; Supplemental bile salts: the good, the bad. Gut 2002;50:701-6.
Am J Gastroenterol. 2003 Apr;98(4):934-935.

14.      Gawrieh S, Shaker R. Peripheral mechanisms affecting the lower esophageal sphincter tone. Gastroenterol Clin North Am. 2002 Dec;31(4 Suppl):S21-33.

15.       Gawrieh S, Massey BT, Komorowski RA. scalp metastases as the first manifestation of pancreatic cancer. Dig Dis Sci. 2002 Jul;47(7):1469-71.

ABSTRACTS

1. Gawrieh S, Marion M, Smith K, Komorowski R, Wallace J, Nuttleman P, Andris D, Kissebah A, Langefeld C, Olivier M. Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with NAFLD and its histological phenotypes. The American College of Gastroenterology Annual Scientific Meeting 2007, Philadelphia, PA.
   
   
2. Surapaneni S, Katopes C, Wallace J, Nuttleman P, Andris D, Behnaz B, Komorowski R, Franco J, Varma R, Massoud O, Saeian K, Gawrieh S. Prediction of histology in nonalcoholic fatty liver disease: do medications matter?. The American College of Gastroenterology Annual Scientific Meeting 2007, Philadelphia, PA.
   
   
3. Katopes CP, Surapaneni S, Komorowski R, Behmaram B, Wallace J, Nuttleman P, Franco J, Varma R, Massoud O, Saeian K, Gawrieh S. Variablility in the Histologic Interpretation of Non-Alcoholic Fatty Liver Disease. Digestive Disease Week 2007, Washington, DC.
4. Gawrieh S, Eckert J; Komorowski R; Cole R; Wallace J; Kissebah A; Olivier M. A Protein Tyrosine Phosphatase 1 Beta (PTP-1B) Risk Haplotype is Associated with Non- Alcoholic Steatohepatitis in Females. AASLD meeting 2006. Boston, MA
   
   
5. Charlton MR, Angulo Hernandez P, Charatcharoenwitthaya P, Burgart L, Gawrieh S, Lindor K;, Viker K, Krishnan A. Low Circulating DHEA Levels in Severe Non-alcoholic Fatty Liver Disease – A Potential Metabolic Basis of Disease Progression. Digestive Disease Week 2006, Los Angeles, CA.
6. Gawrieh S, Eckert J, Komorowski R, Wallace J, Kissebah A, Olivier M. Genetic Variation of Protein Tyrosine Phosphatase 1 Beta in Non-Alcoholic Fatty Liver Disease. Keystone Symposia 2006. Big Sky, MT.
7. Gawrieh S, Papouchado BG, Kobayashi S, Charlton MR, Gores GJ: Mesenchymal hepatic stellate cells activation index predicts progressive hepatitis C virus recurrence after liver transplantation. Oral presentation for AASLD Parallel Session 2004, Boston, MA.
8. Gawrieh S, Rosado B, Lindor K, Charlton MR: Adipokine levels are predictive of histology in patients with non-alcoholic fatty liver disease. Oral Presentation for AASLD Presidential Plenary Session 2004, Boston, MA.
9. Gawrieh S, Jean MC, Massey BT. Not just a failure to relax: Timing and magnitude of lower esophageal sphincter after-contractions also contribute to esophageal outflow obstruction in achalasia. Presented as a Poster of Distinction for DDW 2003, Orlando, FL.
   
10. Gawrieh S, Prajapati DN, Saeian K, Varma RR, Franco J, Knox JF, Kern M, Binion DG.Prevalence
    and patterns of liver tests abnormalities in patients with inflammatory bowel Disease. Presented
    as a poster in AASLD meeting, Boston, MA 2002.
11. Gawrieh S, Hogan WJ, Caroll T, Shaker R. Deglutitive syncope associated with esophageal dysphagia. Presented as a poster At DDW, San Fansisco, CA 2002.